These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10443701)

  • 1. Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation.
    Siggaard C; Rittig S; Corydon TJ; Andreasen PH; Jensen TG; Andresen BS; Robertson GL; Gregersen N; Bolund L; Pedersen EB
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2933-41. PubMed ID: 10443701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1-->Val in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor.
    Repaske DR; Medlej R; Gültekin EK; Krishnamani MR; Halaby G; Findling JW; Phillips JA
    J Clin Endocrinol Metab; 1997 Jan; 82(1):51-6. PubMed ID: 8989232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine(2) in the vasopressin moiety of the hormone precursor.
    Rittig S; Siggaard C; Ozata M; Yetkin I; Gregersen N; Pedersen EB; Robertson GL
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3351-5. PubMed ID: 12107248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation (R97C) in the neurophysin moiety of prepro-vasopressin-neurophysin II associated with autosomal-dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Mol Genet Metab; 1999 May; 67(1):89-92. PubMed ID: 10329029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new mutation of the arginine vasopressin-neurophysin II gene in a family with autosomal dominant neurohypophyseal diabetes insipidus.
    Mundschenk J; Rittig S; Siggaard C; Hensen J; Lehnert H
    Exp Clin Endocrinol Diabetes; 2001; 109(8):406-9. PubMed ID: 11748489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel Ser18del AVP Variant Causes Inherited Neurohypophyseal Diabetes Insipidus by Mechanisms Shared with Other Signal Peptide Variants.
    Toustrup LB; Kvistgaard H; Palmfeldt J; Bjerre CK; Gregersen N; Rittig S; Corydon TJ; Christensen JH
    Neuroendocrinology; 2018; 106(2):167-186. PubMed ID: 28494452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dilatative uropathy as a manifestation of neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin-neurophysin-II gene.
    Lindenthal V; Mainberger A; Morris-Rosendahl DJ; Löning L; Mayer W; Müller HL
    Klin Padiatr; 2013 Dec; 225(7):407-12. PubMed ID: 24158882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of Glu78 of the AVP-NPII gene impairs neurophysin as a carrier protein for arginine vasopressin in a family with neurohypophyseal diabetes insipidus.
    Lee YW; Lee KW; Ryu JW; Mok JO; Ki CS; Park HK; Kim YJ; Kim SJ; Byun DW; Suh KI; Yoo MH; Shin HB; Lee YK; Kim CH
    Ann Clin Lab Sci; 2008; 38(1):12-4. PubMed ID: 18316776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense mutation in the arginine-vasopressin neurophysin-II gene causes autosomal dominant neurohypophyseal diabetes insipidus in a Chinese family.
    Ye D; Dong F; Lu W; Zhang Z; Lu X; Li C; Liu Y
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):920-5. PubMed ID: 23252994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant neurohypophyseal diabetes insipidus in a Swiss family, caused by a novel mutation (C59Delta/A60W) in the neurophysin moiety of prepro-vasopressin-neurophysin II (AVP-NP II).
    Flück CE; Deladoëy J; Nayak S; Zeller O; Kopp P; Mullis PE
    Eur J Endocrinol; 2001 Oct; 145(4):439-44. PubMed ID: 11581002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus.
    Nagasaki H; Ito M; Yuasa H; Saito H; Fukase M; Hamada K; Ishikawa E; Katakami H; Oiso Y
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1352-6. PubMed ID: 7714110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal dominant neurohypophyseal diabetes insipidus with linkage to chromosome 20p13 but without mutations in the AVP-NPII gene.
    Ye L; Li X; Chen Y; Sun H; Wang W; Su T; Jiang L; Cui B; Ning G
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4388-93. PubMed ID: 15811933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus.
    Calvo B; Bilbao JR; Urrutia I; Eizaguirre J; Gaztambide S; Castaño L
    J Clin Endocrinol Metab; 1998 Mar; 83(3):995-7. PubMed ID: 9580132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel splice site mutation of the arginine vasopressin-neurophysin II gene identified in a kindred with autosomal dominant familial neurohypophyseal diabetes insipidus.
    Tae HJ; Baek KH; Shim SM; Yoo SJ; Kang MI; Cha BY; Lee KW; Son HY; Kang SK
    Mol Genet Metab; 2005; 86(1-2):307-13. PubMed ID: 16006166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forty-One Individuals With Mutations in the AVP-NPII Gene Associated With Familial Neurohypophyseal Diabetes Insipidus.
    García-Castaño A; Madariaga L; Pérez de Nanclares G; Vela A; Rica I; Gaztambide S; Martínez R; Martinez de LaPiscina I; Urrutia I; Aguayo A; Velasco O; ; Castaño L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32052034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analyses of three different mutations in the AVP-NPII gene causing familial neurohypophyseal diabetes insipidus.
    Türkmen MÖ; Karaduman T; Tuncdemir BE; Ünal MA; Mergen H
    Endocrine; 2021 Dec; 74(3):658-665. PubMed ID: 34232487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an AVP-NPII mutation within the AVP moiety in a family with neurohypophyseal diabetes insipidus: review of the literature.
    Koufaris C; Alexandrou A; Sismani C; Skordis N
    Hormones (Athens); 2015; 14(3):442-6. PubMed ID: 26233932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular analysis of three families with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel and recurrent mutations in the vasopressin-neurophysin II gene.
    Rutishauser J; Kopp P; Gaskill MB; Kotlar TJ; Robertson GL
    Eur J Endocrinol; 2002 May; 146(5):649-56. PubMed ID: 11980620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus.
    Rutishauser J; Böni-Schnetzler M; Böni J; Wichmann W; Huisman T; Vallotton MB; Froesch ER
    J Clin Endocrinol Metab; 1996 Jan; 81(1):192-8. PubMed ID: 8550751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AVP-NPII gene mutations and clinical characteristics of the patients with autosomal dominant familial central diabetes insipidus.
    Turkkahraman D; Saglar E; Karaduman T; Mergen H
    Pituitary; 2015 Dec; 18(6):898-904. PubMed ID: 26134705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.